Feeling tired, foggy, unusually hungry, unfocused, or unlike yourself is worth paying attention to. Symptoms are data—not character flaws, proof that you lack discipline, or a diagnosis you should try to make on your own. Start by noticing the pattern, then bring the pattern to a licensed provider who can help put it in context.
Fatigue is a symptom, not a disease, and it can have many possible contributors—from insufficient sleep and stress to medications, mood concerns, or medical conditions. That is why a useful next step is not a self-diagnosis; it is a clear conversation about what has changed, how long it has been happening, and what else you are noticing. MedlinePlus’ overview of fatigue recommends contacting a health care provider when tiredness has persisted for weeks.
Start with the pattern, not the label.
You do not need to have the perfect explanation before asking for help. A short record of when symptoms show up, what improves or worsens them, changes in sleep, appetite, activity, medications, and stress can make a clinical conversation more productive. Providers commonly ask about sleep, daily activities, appetite, and exercise when evaluating ongoing fatigue. MedlinePlus
Your symptom-to-signal map
These categories are starting points for observation—not a diagnostic test. One symptom can have more than one driver, and several symptoms can share a driver.
| What you notice | A useful signal to explore | Start here |
|---|---|---|
| Energy | A predictable afternoon drop, all-day exhaustion, or a change from your usual baseline is a pattern worth writing down and discussing rather than blaming on your work ethic. MedlinePlus | Why the 2 PM Crash Isn’t a Character Flaw |
| Sleep | Trouble falling asleep, staying asleep, or waking refreshed is a concrete pattern to record and discuss with a provider if it persists. | The 2 A.M. Problem |
| Weight | A change in weight or the way your body feels can be a cue for a fuller conversation than “eat less, move more.” | The Hidden Map of Body Fat, Part 1 · Part 2 · Part 3 · Part 4 |
| Focus | Feeling mentally slowed, distractible, or “foggy” is useful context to record, especially when it is new or affecting daily life. | Why the 2 PM Crash Isn’t a Character Flaw |
| Motivation | When motivation changes alongside energy, sleep, appetite, or weight, treat it as a pattern worth discussing—not as a moral verdict about you. | The GLP-1 Users Who Regain Everything Have One Thing in Common |
A practical first step: the Metabolic Friction Assessment
Not sure where to begin? The Metabolic Friction Assessment takes 8 questions and about 2 minutes. Then we’ll email you a personalized 7-Day Reset—a practical way to organize what you are noticing and choose a next step.
It is not a medical exam, diagnosis, or substitute for care. Think of it as a short check-in that can help you turn “I just don’t feel right” into a more useful starting point for yourself and, if needed, a licensed provider.
Take the Metabolic Friction Assessment →
Hunger, fullness, and weight are not just willpower
Hunger and fullness are worth treating as signals—not as a willpower score. Research supported by the National Institute of Diabetes and Digestive and Kidney Diseases describes feeding behavior as an integration of internal state, peripheral signals, experience, and context—not one simple switch controlled by discipline. NIDDK’s appetite research overview
A useful first step is not assuming that one explanation fits every pattern. If you repeatedly feel hungry soon after eating, think about food constantly, or find that plans become impossible to sustain, approach the pattern with more curiosity and less shame.
- Learn to notice the signal before you override it. The Hunger Signal Most Diet Plans Train You to Ignore explores why rigid rules can make it harder to recognize hunger and fullness cues.
- Look beyond the scale. The Hidden Map of Body Fat series explains why location and context matter in conversations about body composition. Continue with Part 2 and Part 3.
- Build for the long run. The GLP-1 Users Who Regain Everything Have One Thing in Common looks at the habits and support systems that matter after the first burst of motivation.
The goal is not to turn every normal fluctuation into a problem. It is to make your next decision from better information: what is happening, when it happens, what has changed, and where a provider’s perspective could help.
When it is time to talk to a licensed provider
Consider making an appointment when symptoms are persistent, worsening, disrupting work or relationships, or do not improve after a few weeks. A provider can review your history, medications, sleep, daily routines, and other symptoms; depending on the situation, they may recommend an exam, testing, treatment, or a referral. MedlinePlus
Bring a short timeline rather than trying to tell the whole story at once:
- What changed? Note when the symptom began and whether it was sudden or gradual.
- What else changed with it? Sleep, mood, appetite, weight, digestion, activity, stress, and medications are all useful context.
- What is the impact? Be specific: missing workouts, falling asleep at work, difficulty concentrating, or avoiding plans.
- What have you already tried? Include what helped, what did not, and any supplements or medicines you use.
If you have severe symptoms, a sudden deterioration, or think you may need urgent care, seek medical attention promptly rather than waiting for an online assessment.
Compounded GLP-1 medications: what the FDA currently says
Evidence-aware note
GLP-1 medicines are an important topic, but they are not a shortcut around clinical judgment. The right question is not “Can I get one?” It is “What is appropriate and safe for my situation—and how will it be monitored?”
FDA says compounded drugs, including compounded GLP-1 products, are not FDA-approved and do not receive the agency’s premarket review for safety, effectiveness, or quality. FDA advises that compounded drugs should be used only when a patient’s medical needs cannot be met by an FDA-approved drug. FDA: concerns with unapproved GLP-1 drugs
The regulatory context also changed as supply stabilized. FDA determined the tirzepatide injection shortage was resolved in December 2024 and the semaglutide injection shortage was resolved in February 2025; in its April 2026 update, FDA says semaglutide and tirzepatide do not currently appear on its drug-shortage list and reiterates restrictions on compounding products that are essentially copies of commercially available drugs. FDA’s GLP-1 compounding policy update
This is not a reason to panic or to make a medication decision from a headline. It is a reason to use a licensed prescriber, ask which product is being prescribed and why, confirm the dispensing pharmacy is state-licensed, and understand exactly how to use the medication. FDA has specifically reported dosing errors with compounded semaglutide vials and variable concentrations, including errors linked to confusion among milligrams, milliliters, and “units.” FDA’s dosing-error alert
Frequently asked questions
Why do I feel tired all the time?
There is no single answer. Fatigue can be related to sleep, stress, lifestyle patterns, medications, mental health concerns, or a range of medical conditions. If it has lasted for weeks, is getting worse, or is interfering with daily life, talk with a licensed provider instead of assuming it is something you need to push through. MedlinePlus
Is brain fog a diagnosis?
“Brain fog” is a broad, non-specific term rather than a diagnosis by itself; a 2025 review notes that it can refer to overlapping cognitive, fatigue, and affective symptoms across conditions. Defining Brain Fog: a transdiagnostic narrative review Describe exactly what you notice, track when it happens and what comes with it, then discuss the full pattern with a licensed provider.
Why am I hungry even when I am trying to eat well?
Hunger and eating behavior reflect more than intention. The brain integrates internal signals and context when regulating feeding behavior, so it can be more useful to observe your hunger and fullness patterns than to answer them with more restriction or self-criticism. NIDDK’s appetite research overview
Are compounded GLP-1 medications the same as FDA-approved medications?
No. FDA says compounded drugs are not FDA-approved and are not reviewed by the agency before marketing for safety, effectiveness, or quality. A licensed provider can help you understand whether a treatment is appropriate for your needs, what product is being prescribed, and how it should be monitored. FDA
Get a clearer next step
You do not have to explain every symptom perfectly before you ask for help. Start with the pattern, bring your questions, and use a structured check-in to organize what you are noticing before your next conversation with a provider.
Take the Metabolic Friction Assessment →
Sources
- MedlinePlus — Fatigue
- National Institute of Diabetes and Digestive and Kidney Diseases — About Our Research: Motivational Processes Underlying Appetite
- U.S. Food and Drug Administration — FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- U.S. Food and Drug Administration — FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
- 2025 review — Defining Brain Fog: A Transdiagnostic Narrative Review
- U.S. Food and Drug Administration — FDA alerts health care providers, compounders and patients of dosing errors associated with compounded semaglutide injectable products